RYN Stock Analysis: Rayonier | NYSE
REIT - Specialty | NYSE, USA | Market Cap: 6.477m USD | 12M Return: 0.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 55.5M
EPS Trend: 90.1%
Qual. Beats: 0
Rev. Trend: -27.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Rayonier Inc. (NYSE: RYN) is a timberland-focused real estate investment trust (REIT) that owns and manages more than four million acres of forestland across the U.S. South and Pacific Northwest. The company operates a diversified land resources business that includes six sawmills, an industrial-grade plywood mill, residential and commercial real estate development, and a rural land sales program. Rayonier emphasizes sustainable forest management, third-party certification, and carbon-related land-based solutions as part of its corporate responsibility framework. Headquartered in Yulee, Florida, the company has been incorporated since 1926 and has been publicly traded since its 1994 IPO.
Timber REITs, the GICS sub-industry in which Rayonier operates, typically generate revenue through a mix of timber harvesting, sawlog and pulpwood sales, land leasing (including hunting and recreational leases), and periodic higher-value land sales such as conservation easements or property conversions to higher uses. Unlike traditional equity REITs that lease buildings, timber REITs rely on biological asset growth, meaning their underlying inventory appreciates naturally over time between harvest cycles. As REITs, these companies are generally required to distribute the majority of their taxable income to shareholders, which often makes them income-oriented holdings.
- Housing starts recovery lifts timber prices and harvest volumes
- Sawmill margins face pressure as lumber prices retreat from highs
- Pacific Northwest wildfire risk threatens timberland harvest capacity
| Net Income: 465.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.71 > 1.0 |
| NWC/Revenue: 77.42% < 20% (prev 43.90%; Δ 33.52% < -1%) |
| CFO/TA 0.03 > 3% & CFO 263.5m > Net Income 465.4m |
| Net Debt (1.42b) to EBITDA (206.1m): 6.91 < 3 |
| Current Ratio: 3.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (162.2m) vs 12m ago 5.53% < -2% |
| Gross Margin: 15.66% > 18% (prev 40.91%; Δ -25.25% > 0.5%) |
| Asset Turnover: 12.23% > 50% (prev 32.94%; Δ -20.71% > 0%) |
| Interest Coverage Ratio: 1.72 > 6 (EBIT TTM 66.8m / Interest Expense TTM 38.8m) |
| A: 0.07 (Total Current Assets 735.9m - Total Current Liabilities 210.6m) / Total Assets 7.75b |
| B: 0.02 (Retained Earnings 156.2m / Total Assets 7.75b) |
| C: 0.01 (EBIT TTM 66.8m / Avg Total Assets 5.55b) |
| D: 2.24 (Book Value of Equity 5.33b / Total Liabilities 2.38b) |
| Altman-Z'' = 2.95 = A |
| DSRI: 3.0 (Receivables 53.8m/17.2m, Revenue 678.4m/1.10b) |
| GMI: 2.61 (GM 40.91% / 15.66%) |
| AQI: 0.09 (AQ_t 0.07 / AQ_t-1 0.76) |
| SGI: 0.61 (Revenue 678.4m / 1.10b) |
| TATA: 0.03 (NI 465.4m - CFO 263.5m) / TA 7.75b) |
| Beneish M = -0.73 (Cap -4..+1) = D |
As of July 11, 2026, the stock is trading at USD 21.27 with a total of 1,167,998 shares traded. Over the past week, the price has changed by -1.02%, over one month by +4.06%, over three months by +1.56% and over the past year by +0.58%.
Current recommended Stop Loss: 20.50 (which is 3.6% or 1.5 ATR below the current price).
Rayonier has received a consensus analysts rating of 3.57. Therefore, it is recommended to hold RYN.
- StrongBuy: 1
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 26 | 22.2% |
P/E Trailing = 46.5543
P/E Forward = 46.729
P/S = 9.5809
P/B = 1.2127
P/EG = 23.2357
Revenue TTM = 678.4m USD
EBIT TTM = 66.8m USD
EBITDA TTM = 206.1m USD
Long Term Debt = 1.86b USD (from longTermDebt, last quarter)
Short Term Debt = 210.6m USD (from shortTermDebt, last quarter)
Debt = 2.10b USD (from shortLongTermDebtTotal, last quarter) + Leases 13.7m
Net Debt = 1.42b USD (calculated: Debt 2.10b - CCE 682.0m)
Enterprise Value = 7.90b USD (6.48b + Debt 2.10b - CCE 682.0m)
Interest Coverage Ratio = 1.72 (Ebit TTM 66.8m / Interest Expense TTM 38.8m)
EV/FCF = 38.50x (Enterprise Value 7.90b / FCF TTM 205.2m)
FCF Yield = 2.60% (FCF TTM 205.2m / Enterprise Value 7.90b)
FCF Margin = 30.25% (FCF TTM 205.2m / Revenue TTM 678.4m)
Net Margin = 68.60% (Net Income TTM 465.4m / Revenue TTM 678.4m)
Gross Margin = 15.66% ((Revenue TTM 678.4m - Cost of Revenue TTM 572.2m) / Revenue TTM)
Gross Margin QoQ = -3.50% (prev 41.96%)
Tobins Q-Ratio = 1.02 (Enterprise Value 7.90b / Total Assets 7.75b)
Interest Expense / Debt = 1.85% (Interest Expense 38.8m / Debt 2.10b)
Taxrate = 0.67% (500k / 74.6m)
NOPAT = 66.4m (EBIT 66.8m * (1 - 0.67%))
Current Ratio = 3.49 (Total Current Assets 735.9m / Total Current Liabilities 210.6m)
Debt / Equity = 0.39 (Debt 2.10b / totalStockholderEquity, last quarter 5.33b)
Debt / EBITDA = 6.91 (Net Debt 1.42b / EBITDA 206.1m)
Debt / FCF = 6.94 (Net Debt 1.42b / FCF TTM 205.2m)
Total Stockholder Equity = 3.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.39% (Net Income 465.4m / Total Assets 7.75b)
RoE = 15.36% (Net Income TTM 465.4m / Total Stockholder Equity 3.03b)
RoCE = 1.37% (EBIT 66.8m / Capital Employed (Equity 3.03b + L.T.Debt 1.86b))
RoIC = 0.86% (NOPAT 66.4m / Invested Capital 7.71b)
WACC = 5.47% (E(6.48b)/V(8.58b) * Re(6.65%) + D(2.10b)/V(8.58b) * Rd(1.85%) * (1-Tc(0.01)))
Discount Rate = 6.65% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 80.90 | Cagr: 3.17%
[DCF] Terminal Value 77.97% ; FCFF base≈181.6m ; Y1≈208.1m ; Y5≈306.3m
[DCF] Fair Price = 10.60 (EV 4.61b - Net Debt 1.42b = Equity 3.19b / Shares 300.7m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 90.12 | EPS CAGR: 28.80% | SUE: 0.50 | # QB: 0
Revenue Correlation: -27.00 | Revenue CAGR: -7.23% | SUE: 0.02 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.10 | Chg30d=-11.68% | Revisions=-17% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.17 | Chg30d=+7.86% | Revisions=+17% | Analysts=4
EPS current Year (2026-12-31): EPS=0.47 | Chg30d=+13.56% | Revisions=+17% | GrowthEPS=-17.4% | GrowthRev=+200.3%
EPS next Year (2027-12-31): EPS=0.66 | Chg30d=+4.80% | Revisions=+17% | GrowthEPS=+40.1% | GrowthRev=+10.0%
[Analyst] Revisions Ratio: +13% (up=7, down=5)